Astellas Pharma Inc: all 983 studies
Page 9 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular DegenerationCompletedNCT00782093Phase 1
- Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy VolunteersCompletedNCT00776516Phase 1
- Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic HyperplasiaCompletedNCT00771394Phase 4
- A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional DyspepsiaCompletedNCT00764374Phase 3
- A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal ImpairmentCompletedNCT00750620Phase 1
- A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNCT00739453Phase 1
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.CompletedNCT00720408Phase 3
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation PatientsCompletedNCT00720265Phase 3
- Drug-Drug Interaction Study of TRK-100STPCompletedNCT00719758Phase 1
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant RecipientsCompletedNCT00719745Phase 3
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant RecipientsCompletedNCT00717678Phase 3
- A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney RejectionCompletedNCT00717470Phase 4
- Study of Tacrolimus Immunosuppressive Therapy After Kidney TransplantationCompletedNCT00717379Phase 4
- ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular DegenerationCompletedNCT00709527Phase 1
- Study of Oral OSI-027 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00698243Phase 1
- Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TXCompletedNCT00693524Phase 2
- Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney TransplantationCompletedNCT00693381Phase 3
- Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque PsoriasisCompletedNCT00692172Phase 3
- Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisCompletedNCT00691262Phase 3
- Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic DermatitisCompletedNCT00691145Phase 3
- Protopic Ointment in Adult Atopic Eczema of the FaceCompletedNCT00690105Phase 4
- Protopic Ointment in Children Atopic EczemaCompletedNCT00689832Phase 4
- A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00674063Phase 3
- Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic DermatitisCompletedNCT00673725Phase 4
- A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or InappropriateCompletedNCT00673556Phase 3
- A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831CompletedNCT00668070Phase 2
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisCompletedNCT00667160Phase 4
- Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact DermatitisCompletedNCT00667056Phase 4
- A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNCT00666302Phase 4
- Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal CandidiasisCompletedNCT00666185Phase 3
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisCompletedNCT00666159Phase 4
- Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCompletedNCT00665639Phase 3
- A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic ArthritisCompletedNCT00659412Phase 2
- A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy VolunteersCompletedNCT00653822Phase 1
- Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With PolysomnographyCompletedNCT00653562Phase 4
- A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant PatientsCompletedNCT00650468Phase 4
- Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsCompletedNCT00643071Phase 3
- Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)CompletedNCT00637143Phase 4
- Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisCompletedNCT00629642Phase 4
- A Study of ASP1941 in Participants With Type 2 Diabetes MellitusCompletedNCT00621868Phase 2
- A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation PatientsCompletedNCT00619398Phase 3
- Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 1
- Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00607763Phase 1
- A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell TransplantCompletedNCT00606268Phase 1
- Phase I Study of OSI-930 and Erlotinib in Cancer TumorsCompletedNCT00603356Phase 1
- A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement SurgeryCompletedNCT00595426Phase 2
- A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular DegenerationCompletedNCT00569140Phase 1
- Phase II Study of ASP3550 in Patients With Prostate CancerCompletedNCT00568516Phase 2
- Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567918Phase 3
- Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567762Phase 3
- Long-term Safety of Protopic in Atopic EczemaCompletedNCT00560378Phase 3
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisCompletedNCT00560326Phase 2
- Tacrolimus Ointment Pharmacokinetics in Infants With Atopic DermatitisCompletedNCT00535691Phase 2
- Distribution of Tacrolimus in Skin, Atopic DermatitisCompletedNCT00534508Phase 2
- ASP8825 - Study in Patients With Restless Legs SyndromeCompletedNCT00530530Phase 2
- A Study of YM178 in Patients With Symptomatic Overactive BladderCompletedNCT00527033Phase 2
- Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult PatientsCompletedNCT00523952Phase 3
- AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate CancerCompletedNCT00519233Phase 1
- Study of Intermittent OSI-906 DosingCompletedNCT00514306Phase 1
- An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid TumorsCompletedNCT00514267Phase 1/2
- Study of Continuous OSI-906 DosingCompletedNCT00514007Phase 1
- Phase 1 Study of OSI-930 in Cancer PatientsCompletedNCT00513851Phase 1
- A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft FailureCompletedNCT00510913Phase 4
- A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPHCompletedNCT00510406Phase 2
- ASP 8825 - Study in Patients With Painful Diabetic PolyneuropathyTerminatedNCT00508430Phase 2
- A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT00505037Phase 2
- Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) SubjectsTerminatedNCT00498914Phase 2
- Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisCompletedNCT00493324Phase 4
- Dose-finding Study of ASP2151 in Subjects With Herpes ZosterCompletedNCT00487682Phase 2
- A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedNCT00486200Phase 2
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney TransplantationCompletedNCT00481819Phase 3
- Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant SubjectsCompletedNCT00481481Phase 3
- Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus OintmentCompletedNCT00480896Phase 3
- Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus OintmentCompletedNCT00480610Phase 3
- Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder SymptomsCompletedNCT00463541Phase 3
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver TransplantationCompletedNCT00459719Phase 3
- A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)CompletedNCT00454896Phase 3
- Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive BladderCompletedNCT00454740Phase 3
- Assessment and Tracking of Long-term Alefacept SafetyTerminatedNCT00454701
- A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus SubjectsCompletedNCT00454233Phase 2
- A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant PatientsCompletedNCT00451932Phase 2
- Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial FibrillationCompletedNCT00448214Phase 2
- Zolpidem Postmarketing Study in Adolescent Patients With InsomniaCompletedNCT00432198Phase 4
- Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative StudyCompletedNCT00429377Phase 3
- A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisWithdrawnNCT00423163Phase 4
- Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute WardTerminatedNCT00418873Phase 4
- Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid ArthritisCompletedNCT00411424Phase 1/2
- Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary PlaqueCompletedNCT00408382Phase 4
- Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee ReplacementCompletedNCT00408239Phase 2
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver RecipientsCompletedNCT00384202Phase 3
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney RecipientsCompletedNCT00384137Phase 3
- A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.CompletedNCT00379067Phase 4
- A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARDCompletedNCT00378690Phase 3
- Micafungin Salvage Mono-therapy in Invasive AspergillosisTerminatedNCT00376337Phase 2
- A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia PatientsCompletedNCT00374777Phase 3
- Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) ProgramCompletedNCT00371774
- A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder PatientsCompletedNCT00368706Phase 3
- Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)CompletedNCT00353678Phase 2
- Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis PatientsCompletedNCT00347048Phase 3
- AMEVIVE® Pregnancy RegistryTerminatedNCT00342862